Though there has been considerable biological and political debate over the use of embryonic stem cells (ESCs) vs. adult stem cells (ASCs) as therapies for tissue engineering and organ transplants, inherent benefits and drawbacks in both techniques compel
A team led by University of California San Diego neurobiologists has developed a new approach to interpreting brain electroencephalograms, or EEGs, that provides an unprecedented view of thought in action
Genetic mutations, sudden, random and usually harmful changes to the structure of a gene, are only one factor that determines the ultimate fate of a cell. Chicago scientists have discovered that a non-genetic
A new approach to therapy can avoid most of the debilitating effects of preparing for critical, postsurgical treatment for patients with thyroid cancer, according to an international study led by researchers from Johns Hopkin
Dr Chris Underwood of CuMedica has developed a new type of material that could revolutionise surgery and save lives - cellular perfluoroela
The Human Fertilisation and Embryology Authority reviews the first request by British scientists to clone human embryos today. The Newcastle Univers
Professor Snyder's creativity machine was developed at the Centre for the Mind, a joint venture between The Australian National University and the University of Sydney. The machine transmits harmless magnetic pulses
The Human Fertilisation & Embryology Authority (HFEA) is currently considering a licence application from the Newcastle Fertility Centre at Life to make human embryonic stem cells using cell nuclear transfer - a technique also known as therapeutic c
A new computer cluster funded by the University of Sheffield and located within the Royal Hallamshire Hospital, will help scientists to improve their understanding of how human cells and organs work. This will ultimatel
The commercial launch of the first ever fool-proof document security system is planned for 2006, reports Marina Murphy in Chemistry & Industry magazine. The system, which uses DNA fingerprinting, will allow documents to be authenticated with an accurac
Date: Monday, 29-Jan-2007
One approach to developing tumor-specific drug delivery agents is to create nanomaterials that release a therapeutic payload only after reaching their intended target.Researchers at the University of Aarhus, in Denmark, have taken such an approach to develop nanocarriers that can be triggered to deliver genes to diseased tissues.
Reporting its work in the journal Small, a team of investigators led by Kenneth Howard, Ph.D., and Flemming Besenbacher, Ph.D., described how they developed a temperature-sensitive polymer capable of complexing with DNA and forming nanorods that are stable at body temperature, or 37?C. However, when heated to 42?C, these rods expand dramatically, becoming too large to pass into or out of blood vessels. The researchers note that localized heating could be used to trap these nanorods in tumors, in essence creating a new way of targeting a drug delivery agent to tumors.
When exposed to the unique physiological conditions found inside tumors, these nanorods display another useful characteristic - they fall apart. The researchers believe that this disassembly is thorough enough that the polymer no longer complexes at all with the DNA cargo. Electron microscopy studies appear to confirm this finding, suggesting that these nanorods could indeed deliver therapeutic genes into cancer cells.
This work is detailed in a paper titled, "Nanocarrier stimuli-activated gene delivery." Investigators from Wayne State University also participated in this study. An abstract of this paper is available at the journal's website. View abstract.
http://nano.cancer.gov